CWM
CASI

Concert Wealth Management’s CASI Pharmaceuticals CASI Stock Holding History

Concert Wealth Management’s Portfolio CASI Stock Details CASI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-4,167
Closed -$45K – 693
2015
Q3 		$45K Buy
+4,167
New +$60K 0.01% 688

Other funds holding CASI

WSC
Wellington Shields & Co New York $446M AUM 38.92% 1-Year Est. Return
WSCM
Wellington Shields Capital Management New York $788M AUM 66.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
MC
Moors & Cabot Boston, Massachusetts $2.57B AUM 37.84% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Concert Wealth Management's CASI Position: Q4 2015 in Review

Concert Wealth Management sold out of CASI Pharmaceuticals (CASI) in Q4 2015, closing a stake of 4,167 shares — an estimated $45K sold.

Concert Wealth Management first reported a position in CASI in Q3 2015 and held it in 1 quarter. The position peaked at $45K in Q3 2015. 30 funds tracked by Wall St. Rank hold CASI as of Q4 2015.

  • Concert Wealth Management reported no remaining CASI Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • Concert Wealth Management sold 4,167 CASI Pharmaceuticals shares in Q4 2015, an estimated $45K.
  • Concert Wealth Management first reported a position in CASI Pharmaceuticals in Q3 2015 and held it in 1 quarter.
  • Concert Wealth Management's CASI Pharmaceuticals position peaked at $45K in Q3 2015.
  • 30 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q4 2015.

Based on Concert Wealth Management's 13F filing for Q4 2015, filed 9 Feb 2016.